Cargando…
Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period
BACKGROUND: Methotrexate (MTX) is a second line agent for treatment of sarcoidosis. Its long term safety and efficacy in sarcoidosis remains unclear. METHODS: This was a retrospective review of patients seen at the University of Cincinnati Sarcoidosis Clinic over a six year period. For each visit, c...
Autores principales: | Baughman, Robert P., Cremers, Johanna P., Harmon, Martina, Lower, Elyse E., Drent, Marjolein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690061/ https://www.ncbi.nlm.nih.gov/pubmed/33264378 http://dx.doi.org/10.36141/svdld.v37i3.9362 |
Ejemplares similares
-
Goldilocks, vitamin D and sarcoidosis
por: Baughman, Robert P, et al.
Publicado: (2014) -
COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients
por: Baughman, Robert P., et al.
Publicado: (2021) -
World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of Excellence
por: Baughman, Robert P, et al.
Publicado: (2021) -
Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis
por: Carbone, Roberto G., et al.
Publicado: (2014) -
Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015)